Drug survival und klinische Wirksamkeit von Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab und Tildrakizumab in der Behandlung der Psoriasis: Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment
Saved in:
| Title: | Drug survival und klinische Wirksamkeit von Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab und Tildrakizumab in der Behandlung der Psoriasis: Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment |
|---|---|
| Authors: | Mastorino, Luca, Dapavo, Paolo, Susca, Sara, Cariti, Caterina, Siliquini, Niccolò, Verrone, Anna, Stroppiana, Elena, Ortoncelli, Michela, Quaglino, Pietro, Ribero, Simone |
| Source: | Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG Jan2024; Vol. 22 (1). |
| Journal Info: | Publisher: Wiley-Blackwell ISSN: 1610-0379 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
